FDA updates cybersecurity guidance for medical device makers
The Food and Drug Administration Sept. 26 finalized updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines 鈥渃yber device鈥 as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
The National Security Agency April 23 released a report on operational technology systems that includes recommendations for security policies and technical鈥
Chairperson's File
Cybersecurity and physical threats are unfortunately significant enterprise risks for health care, regardless of size or location. Every hospital, physician鈥
Headline
The Cybersecurity and Infrastructure Security Agency April 17 released guidance to reduce risks associated with a reported breach of Oracle cloud services.鈥
Headline
The National Counterintelligence and Security Center, the FBI, and the Defense Counterintelligence and Security Center yesterday released guidance on鈥
AHA Cyber Intel
While the rate of cyberattacks on hospitals has risen dramatically, the severity of the impacts has also grown exponentially. Let鈥檚 look at the state of cyber鈥
Headline
The House Energy and Commerce Oversight and Investigations Subcommittee April 1 discussed cybersecurity threats in legacy medical devices during a hearing. The鈥